| Masimo (MASI) Upgraded to Strong Buy: What Does It Mean for the Stock? |
Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-02-27 15:00:31 |
Czytaj oryginał (ang.) |
| Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom |
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects. |
zacks.com |
2025-02-27 14:50:18 |
Czytaj oryginał (ang.) |
| MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts |
Masimo's fourth-quarter 2024 results continue to benefit from the strength in its Healthcare and Non-healthcare businesses. |
zacks.com |
2025-02-26 14:05:24 |
Czytaj oryginał (ang.) |
| Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-25 21:01:18 |
Czytaj oryginał (ang.) |
| Masimo (MASI) Tops Q4 Earnings and Revenue Estimates |
Masimo (MASI) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.25 per share a year ago. |
zacks.com |
2025-02-25 20:40:19 |
Czytaj oryginał (ang.) |
| Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript |
Masimo Corporation (NASDAQ:MASI ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development & Investor Relations Katie Szyman - Chief Executive Officer Micah Young - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jason Bednar - Piper Sandler Rick Wise - Stifel Michael Polark - Wolfe Research Vik Chopra - Wells Fargo Mike Matson - Needham Operator Good afternoon, ladies and gentlemen, and welcome to Masimo's Fourth Quarter and Full Year 2024 Earnings Conference Call. The company's press release is available at www.masimo.com. |
seekingalpha.com |
2025-02-25 20:02:44 |
Czytaj oryginał (ang.) |
| Masimo Tops EPS, Revenue Expectations |
Masimo (MASI -0.69%), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong performance was seen in its core healthcare segment, with revenue reaching $601 million, surpassing analyst expectations of $592 million. |
fool.com |
2025-02-25 19:24:02 |
Czytaj oryginał (ang.) |
| Unlocking Q4 Potential of Masimo (MASI): Exploring Wall Street Estimates for Key Metrics |
Besides Wall Street's top -and-bottom-line estimates for Masimo (MASI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024. |
zacks.com |
2025-02-20 12:20:39 |
Czytaj oryginał (ang.) |
| Can Masimo (MASI) Keep the Earnings Surprise Streak Alive? |
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-01-28 15:16:02 |
Czytaj oryginał (ang.) |
| Here's Why Masimo (MASI) is a Great Momentum Stock to Buy |
Does Masimo (MASI) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2025-01-22 15:00:31 |
Czytaj oryginał (ang.) |
| Masimo Taps Katie Szyman as Permanent CEO |
Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co. |
wsj.com |
2025-01-21 19:22:00 |
Czytaj oryginał (ang.) |
| Masimo names Becton Dickinson's Katie Szyman CEO |
Masimo said on Tuesday it has named Becton Dickinson executive Katie Szyman as chief executive officer after a bitter proxy battle with activist hedge fund Politan Capital Management led to the ouster of founder Joe Kiani from the medical device maker's board last year. |
reuters.com |
2025-01-21 18:56:10 |
Czytaj oryginał (ang.) |
| Masimo Announces Leadership Transition |
IRVINE, Calif.--(BUSINESS WIRE)--Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive Officer (“CEO”) of the Company. Interim CEO Michelle Brennan has been appointed Chairman of Masimo's Board and Lead Independent Director Quentin Koffey has been appointed Vice Chairman. All of these changes are effective as of February 12, 2025. Ms. Szyman is currently worldwide president. |
businesswire.com |
2025-01-21 18:00:00 |
Czytaj oryginał (ang.) |
| Masimo Stock Gains Following Solid Preliminary Q4 Revenues |
MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products. |
zacks.com |
2025-01-20 14:11:13 |
Czytaj oryginał (ang.) |
| Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway |
UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second milestone in its collaboration with Masimo through integration with the Masimo Iris® Gateway. |
accesswire.com |
2025-01-13 10:30:00 |
Czytaj oryginał (ang.) |
| Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. |
benzinga.com |
2024-12-27 11:03:58 |
Czytaj oryginał (ang.) |
| 4 Healthcare Technology Innovators to Invest in Before the New Year |
Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT. |
zacks.com |
2024-12-19 14:00:40 |
Czytaj oryginał (ang.) |
| 3 Medical Instruments Industry Stocks to Buy on the GenAI Wave |
MASI, PEN and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar their prospects. |
zacks.com |
2024-12-16 14:16:19 |
Czytaj oryginał (ang.) |
| Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025 |
These mid-cap stocks have the potential to become large-caps in 2025. These are: MTSI, MASI, DRS, CRS, INGR. |
zacks.com |
2024-11-29 17:01:15 |
Czytaj oryginał (ang.) |
| Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference |
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 8:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide arr. |
businesswire.com |
2024-11-26 11:00:00 |
Czytaj oryginał (ang.) |
| Masimo to Present in Stifel 2024 Healthcare Conference |
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industr. |
businesswire.com |
2024-11-13 11:00:00 |
Czytaj oryginał (ang.) |
| Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth |
MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts. |
zacks.com |
2024-11-06 16:35:32 |
Czytaj oryginał (ang.) |
| MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands |
Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business. |
zacks.com |
2024-11-06 12:10:59 |
Czytaj oryginał (ang.) |
| Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript |
Masimo Corporation (NASDAQ:MASI ) Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ET Company Participants Eli Kammerman - VP of Business Development and IR Michelle Brennan - Interim CEO Micah Young - EVP and CFO Bilal Muhsin - COO Conference Call Participants Jason Bednar - Piper Sandler Marie Thibault - BTIG Michael Polark - Wolfe Research Frederick Wise - Stifel Matt Taylor - Jefferies Vik Chopra - Wells Fargo Michael Matson - Needham Jayson Bedford - Raymond James Operator Ladies and gentlemen, good afternoon, and welcome to Masimo's Third Quarter 2024 Earnings Conference Call. The company's press release is available at www.masimo.com. |
seekingalpha.com |
2024-11-05 21:57:08 |
Czytaj oryginał (ang.) |
| Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates |
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-05 21:30:27 |
Czytaj oryginał (ang.) |
| Masimo (MASI) Q3 Earnings and Revenues Top Estimates |
Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago. |
zacks.com |
2024-11-05 20:25:18 |
Czytaj oryginał (ang.) |
| Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth |
Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-29 13:06:26 |
Czytaj oryginał (ang.) |
| Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion |
IRVINE, Calif.--(BUSINESS WIRE)--Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring technology in the ED. |
businesswire.com |
2024-10-29 10:00:00 |
Czytaj oryginał (ang.) |
| Apple wins $250 from Masimo in watch patent trial |
A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn't getting a big payday. |
techcrunch.com |
2024-10-26 19:53:20 |
Czytaj oryginał (ang.) |
| Masimo smartwatches infringe Apple design patents, US jury says |
Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents. |
reuters.com |
2024-10-25 22:16:14 |
Czytaj oryginał (ang.) |
| Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? |
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2024-10-21 17:15:22 |
Czytaj oryginał (ang.) |
| Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors |
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the “Board”), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, “We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals. |
businesswire.com |
2024-10-18 13:00:00 |
Czytaj oryginał (ang.) |
| Why Masimo (MASI) is a Top Momentum Stock for the Long-Term |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-10-16 14:55:47 |
Czytaj oryginał (ang.) |
| Top 2 Health Care Stocks That Are Ticking Portfolio Bombs |
As of Oct. 10, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. |
benzinga.com |
2024-10-10 13:21:53 |
Czytaj oryginał (ang.) |
| Here's Why You Should Add Masimo Stock to Your Portfolio Now |
MASI's R&D activities raise optimism about the stock. |
zacks.com |
2024-10-07 16:06:11 |
Czytaj oryginał (ang.) |